Cleared Traditional

K944247 - CARDIOCHEX CKMB IMMUNOINHIBITION CONTROL
(FDA 510(k) Clearance)

Oct 1994
Decision
61d
Days
Class 1
Risk

K944247 is an FDA 510(k) clearance for the CARDIOCHEX CKMB IMMUNOINHIBITION CONTROL. This device is classified as a Enzyme Controls (assayed And Unassayed) (Class I - General Controls, product code JJT).

Submitted by Cala Diagnostics (Grover Beach, US). The FDA issued a Cleared decision on October 31, 1994, 61 days after receiving the submission on August 31, 1994.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1660.

Submission Details

510(k) Number K944247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 1994
Decision Date October 31, 1994
Days to Decision 61 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code JJT — Enzyme Controls (assayed And Unassayed)
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1660

Similar Devices — JJT Enzyme Controls (assayed And Unassayed)

All 96
SPOTCHECK BLOOD SPOT CONTROL, ASSAYED
K090940 · Astoria-Pacific, Inc. · Dec 2009
MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKER
K062751 · Quantimetrix Corp. · Oct 2006
CLINIQA LIQUID QC CARDIAC MARKER CONTROL LEVELS 1, 2 & 3, TRI-LEVEL
K030768 · Cliniqa Corporation · Mar 2003
ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3
K030102 · Bayer Healthcare, LLC · Jan 2003
LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1, 2, 3, AND TRILEVEL
K021498 · Bio-Rad · May 2002
LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1,2,3, MODELS 646,647,648
K012656 · Bio-Rad · Sep 2001